Its expression is associated with shorter disease-free survival and biochemical recurrence-free survival after radical prostatectomy [58], suggesting a limited correlation between the AR pathway and a role of HMGCS2 in prostate cancer, in line with the uncoupled regulation of RNA vs. protein levels that we observed. Here, HMGCS2 is linked to prostate carcinoma.